Yale University Cancer Center is a clinical research site located in New Haven, Connecticut, United States 06520.
Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.
Yale University Cancer Center has participated in 17 clinical trials with 11 currently active.
Therapeutic areas: Advanced Solid Tumors, Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC).
Sponsors: Astellas Pharma Global Development, Inc., Phanes Therapeutics, Regeneron Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Connecticut · View every site in New Haven
Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Yale University Cancer Center has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Yale University Cancer Center has 17 clinical trials on record, with 11 currently active. Their work covers Advanced Solid Tumors, Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC).
Yale University Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.